Cargando…

Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays

Moderate to severe diarrhea caused by Shigella is a global health concern due to its substantial contribution to morbidity and mortality in children aged <5 years in low- and middle-income countries. Although antibiotic treatment can be effective, emerging antimicrobial resistance, limited access...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaminski, Robert W, Pasetti, Marcela F, Aguilar, Ana Older, Clarkson, Kristen A, Rijpkema, Sjoerd, Bourgeois, A Louis, Cohen, Dani, Feavers, Ian, MacLennan, Calman A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901123/ https://www.ncbi.nlm.nih.gov/pubmed/31816067 http://dx.doi.org/10.1093/cid/ciz909

Ejemplares similares

Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview
por: MacLennan, Calman A, et al.
Publicado: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
por: MacLennan, Calman A, et al.
Publicado: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
por: Talaat, Kawsar R, et al.
Publicado: (2019)

Critical Needs in Advancing Shigella Vaccines for Global Health
por: MacLennan, Calman A, et al.
Publicado: (2021)

Frontiers in Shigella Vaccine Development
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)

The Shigella Vaccines Pipeline
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)

Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella
por: Ndungo, Esther, et al.
Publicado: (2019)

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
por: Cohen, Dani, et al.
Publicado: (2023)

Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
por: Clarkson, Kristen A., et al.
Publicado: (2021)

Salmonella Combination Vaccines: Moving Beyond Typhoid
por: MacLennan, Calman A, et al.
Publicado: (2023)

Consequences of Shigella infection in young children: a systematic review
por: Libby, Tanya E., et al.
Publicado: (2023)

Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
por: Steele, A Duncan, et al.
Publicado: (2020)

Lymphocyte subsets in healthy Malawians: Implications for immunologic assessment of HIV infection in Africa
por: Mandala, Wilson L., et al.
Publicado: (2010)

Typhoid in India: An Age-old Problem With an Existing Solution
por: Kumar, Supriya, et al.
Publicado: (2021)

An O Antigen Capsule Modulates Bacterial Pathogenesis in Shigella sonnei
por: Caboni, Mariaelena, et al.
Publicado: (2015)

Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay
por: Nahm, Moon H., et al.
Publicado: (2018)

Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
por: Pavlinac, Patricia B., et al.
Publicado: (2022)

Editorial Commentary: Out of Africa: Links Between Invasive Nontyphoidal Salmonella Disease, Typhoid Fever, and Malaria
por: MacLennan, Calman A.
Publicado: (2014)

Antibodies and Protection Against Invasive Salmonella Disease
por: MacLennan, Calman A.
Publicado: (2014)

Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex
por: Turbyfill, K. Ross, et al.
Publicado: (2018)

From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine’s Refinement and Evolution
por: Turbyfill, K. Ross, et al.
Publicado: (2022)

Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward
por: McArthur, Monica A., et al.
Publicado: (2017)

Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system
por: Kapoor, Neeraj, et al.
Publicado: (2021)

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries
por: Giersing, Birgitte K, et al.
Publicado: (2023)

Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
por: Kasumba, Irene N, et al.
Publicado: (2023)

Immunological detection assays for recombinant Shiga toxin & Shigella dysenteriae
por: Gupta, Pallavi, et al.
Publicado: (2019)

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (Invaplex(AR)) vaccines
por: Turbyfill, K. Ross, et al.
Publicado: (2023)

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G
por: Clarkson, Kristen A., et al.
Publicado: (2020)

Vaccines against invasive Salmonella disease: Current status and future directions
por: MacLennan, Calman A, et al.
Publicado: (2014)

A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)
por: Uche, Ifeanyi Valentine, et al.
Publicado: (2017)

Epithelial and Neutrophil Interactions and Coordinated Response to Shigella in a Human Intestinal Enteroid-Neutrophil Coculture Model
por: Lemme-Dumit, Jose M., et al.
Publicado: (2022)

A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes
por: Desalegn, Girmay, et al.
Publicado: (2023)

Leukocyte counts and lymphocyte subsets in relation to pregnancy and HIV infection in Malawian women
por: Mandala, Wilson L., et al.
Publicado: (2017)

Age- and sex-related changes in hematological parameters in healthy Malawians
por: Mandala, Wilson L, et al.
Publicado: (2017)

Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications: RELATIVE ACTIVATION OF TLR4 AND TLR2 PATHWAYS IN DIFFERENT MUTANTS
por: Rossi, Omar, et al.
Publicado: (2014)

Systems approach to define humoral correlates of immunity to Shigella
por: Bernshtein, Biana, et al.
Publicado: (2022)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
por: Talaat, Kawsar R., et al.
Publicado: (2021)

Immunological Criteria for Predicting Severe and Complicated Forms of Chickenpox
por: Saburova, O.A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5frtv2fejmk691lcn7od63h1j